Van Hauwermeiren Timothy bought DNLI
November 4, 2025 · Form 4 insider transaction
Van Hauwermeiren Timothy bought 31,897 shares of Denali Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
31,897
Price
$0.00
Total value
N/A
InsiderVan Hauwermeiren Timothy
Role—
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateNovember 4, 2025
Filing dateNovember 6, 2025
Shares owned after31,897
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the shares subject to the option shall vest on November 4, 2026, and an additional 1/48 of the shares subject to the option vest each month thereafter, subject to the Reporting Person remaining a non-employee director of the Issuer through each such date